Journal of Biological Chemistry · 2003 · 45 citations · 32 references
Life SciencesNeurosciencePhysiologyNeurogeneticsPathophysiologyRenal PathophysiologyHereditary Renal DiseasesNeonatal Renal DisordersRenal DiseaseRenal ImpairmentRenal Physiology
Mice deficient for angiotensinogen (AGT), or other components of the renin-angiotensin system, show a high rate of neonatal mortality correlated with severe renal abnormalities including hydronephrosis, hypertrophy of renal arteries, and an impaired ability to concentrate urine. Although transgenic replacement of systemic or adipose, but not renal, AGT in AGT-deficient mice has previously been reported to correct some of these renal abnormalities, the tissue target for this complementation has not been defined. In the current study, we have used a novel transgenic strategy to restore the peptide product of the renin-angiotensin system, angiotensin II, exclusively in the brain of AGT-deficient mice and demonstrate that brain-specific angiotensin II can correct the hydronephrosis and partially correct renal dysfunction seen in AGT-deficient mice. Taken together, these results suggest that the renin-angiotensin system affects renal development and function through systemically accessible targets in the brain.
32
Male–female differences in fertility and blood pressure in ACE-deficient mice
John H. Krege, Simon W. M. John, Laura L. Langenbach et al. · Nature · 1995 · 647 citations
A Noninvasive Computerized Tail-Cuff System for Measuring Blood Pressure in Mice
John H. Krege, Jeffrey B. Hodgin, John R. Hagaman et al. · Hypertension · 1995 · 592 citations
Medicine, Pharmacology, Physiology +17
GFAP promoter directs astrocyte-specific expression in transgenic mice
Michael Brenner, WC Kisseberth, Yuan Su et al. · Journal of Neuroscience · 1994 · 497 citations · Full text
Medicine, Genetics, Neuroscience +17